Life Sciences students trained by Biocon Academy ready to join industry
The third batch of the Biocon Academy commenced on 3rd Nov’ at Bangalore
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Glenmark enrols first patient for phase II trial of GBR 500
The company out licensed Vatelizumab (GBR 500) to Sanofi for all indications in 2011
Ranbaxy obtains US FDA approval to market fenofibrate capsules
Fenofibrate capsules are indicated for primary hypercholesterolemia and mixed dyslipidemia. In addition, it is indicated for…
Glenmark Generics receives final ANDA approval for Omeprazole DR capsules
It is a generic version of Prilosec by AstraZeneca
Study confirms positive safety profile and effectiveness of Pradaxa in atrial fibrillation patients
The US FDA Medicare study of 134,000 patients demonstrates benefits such as a significantly reduced risk of ischaemic stroke, a…
Phase III efficacy clinical study results of Sanofi’s Dengue vaccine candidate published
Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation
Multisorb Technologies appoints Peter Lirusso to Healthcare Packaging Group for Canada
Lirusso brings vast experience in films, foils, and ridged plastics and blister packs within the pharmaceutical industry. And…
Biocon expands its strategic partnership with CytoSorbents
Biocon will now have the exclusive, region-wide rights to distribute CytoSorb for all critical care applications in the ICU as…
Indian Patent office issues new guidelines for pharmaceutical patent applications
Generic disclosure in the prior art may not necessarily take away the novelty of a specific disclosure Taking into account the…
World Ayurveda Congress aims to boost traditional Indian healing systems
200 practitioners to attend Nov 6-7 healers meet